FRAILTY ASSESSMENT AND 6-MONTH FUNCTIONAL STATUS AND MORTALITY AFTER AORTIC VALVE REPLACEMENT

D. Kim,C. Kim,F. D. Grodstein,J. J. Popma,K. Khabbaz,R. Laham,K. Guibone,J. Afilalo,L. A. Lipsitz
DOI: https://doi.org/10.1093/geroni/igx004.4679
2017-01-01
Innovation in Aging
Abstract:Preoperative frailty assessment may be useful to predict functional status and mortality in older adults undergoing aortic valve replacement (AVR). We conducted a single-center prospective cohort study to compare frailty phenotype versus comprehensive geriatric assessment-based frailty index (CGA-FI) in predicting 6-month functional status and mortality after transcatheter and surgical AVR. Between February 2014 and December 2015, we assessed frailty phenotype and CGA-FI in patients 70 years or older who underwent transcatheter AVR (N=124) or surgical AVR (N=88). Telephone interviews were performed at 1, 3, and 6 months to assess the ability to perform 22 functional activities. The composite poor clinical outcome, defined as death or functional decline with the New York Heart Association class 3 or 4, occurred in 31 (26%) of 120 transcatheter AVR patients (drop-out: 4) and 8 (11%) of 76 surgical AVR patients (drop-out: 12). The risk of poor clinical outcome did not differ between patients with and without frailty phenotype undergoing transcatheter AVR (24 of 96 [25%] versus 7 of 24 [29%]; p=0.68) and surgical AVR (5 of 27 [19%] versus 3 of 49 [6%]; p=0.11). However, the risk increased with CGA-FI (≤0.20, 0.21–0.40, >0.40) in transcatheter AVR (1 of 12 [8%], 12 of 64 [19%], 18 of 44 [41%]; p=0.01) and surgical AVR (1 of 29 [3%], 5 of 42 [12%], 2 of 5 [40%]; p=0.04). In conclusion, CGA-FI predicts 6-month functional status and mortality after transcatheter and surgical AVR, but frailty phenotype has a limited role in this population with high prevalence of frailty.
What problem does this paper attempt to address?